Credit Suisse Maintains Neutral on PepsiCo, Raises Price Target to $170
Credit Suisse analyst Kaumil Gajrawala maintains PepsiCo (NASDAQ:PEP) with a Neutral and raises the price target from $168 to $170.
Raymond James Maintains Outperform on Leap Therapeutics, Lowers Price Target to $3
Raymond James analyst Steven Seedhouse maintains Leap Therapeutics (NASDAQ:LPTX) with a Outperform and lowers the price target from $4 to $3.
Raymond James Maintains Strong Buy on Dave & Buster’s Enter, Lowers Price Target to $55
Raymond James analyst Brian Vaccaro maintains Dave & Buster's Enter (NASDAQ:PLAY) with a Strong Buy and lowers the price target from $60 to $55.
Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $45
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $40 to $45.
Wells Fargo Maintains Equal-Weight on Honeywell Intl, Lowers Price Target to $180
Wells Fargo analyst Joseph O'Dea maintains Honeywell Intl (NASDAQ:HON) with a Equal-Weight and lowers the price target from $183 to $180.
BMO Capital Maintains Outperform on New Gold, Lowers Price Target to C$2
BMO Capital analyst Brian Quast maintains New Gold (TSX:NGD) with a Outperform and lowers the price target from C$3 to C$2.
Wells Fargo Maintains Equal-Weight on Eaton Corp, Lowers Price Target to $139
Wells Fargo analyst Joseph O'Dea maintains Eaton Corp (NYSE:ETN) with a Equal-Weight and lowers the price target from $142 to $139.
Wells Fargo Maintains Equal-Weight on Dover, Lowers Price Target to $134
Wells Fargo analyst Joseph O'Dea maintains Dover (NYSE:DOV) with a Equal-Weight and lowers the price target from $135 to $134.
B of A Securities Maintains Underperform on RPM International, Lowers Price Target to $78
B of A Securities analyst Steve Byrne maintains RPM International (NYSE:RPM) with a Underperform and lowers the price target from $90 to $78.
B of A Securities Maintains Buy on Univar Solns, Lowers Price Target to $34
B of A Securities analyst Steve Byrne maintains Univar Solns (NYSE:UNVR) with a Buy and lowers the price target from $36 to $34.